Bansal N. Prediabetes diagnosis and treatment: a review. World J Diabetes. 2015;6(2):296.
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–90.
Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T et al. Idf diabetes atlas. 2019.
Wagenaar P, Hardy G. Cde watch: 2012 update from the centres for diabetes excellence: summaries. S Afr J Diabetes Vasc Dis. 2012;9(4):183–8.
Heraclides AM, Chandola T, Witte DR, Brunner EJJO. Work stress, obesity and the risk of type 2 diabetes: gender-specific bidirectional effect in the Whitehall II study. Obesity. 2012;20(2):428–33.
Hu FB, Van Dam R, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 2001;44(7):805–17.
Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J. 2014;18(3):88.
Falco G, Pirro P, Castellano E, Anfossi M, Borretta G, Gianotti L, et al. The relationship between stress and diabetes mellitus. J Neurol Psychol. 2015;3(1):1–7.
Bose M, Oliván B, Laferrère B. Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes. 2009;16(5):340.
Guilliams TG, Edwards L. Chronic stress and the Hpa axis. Standard. 2010;9(2):1–12.
Rosmond R. Stress induced disturbances of the Hpa axis: a pathway to type 2 diabetes? Med Sci Monit. 2003;9(2):RA35–9.
Christiansen JJ, Djurhuus CB, Gravholt CH, Iversen P, Christiansen JS, Schmitz O, et al. Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J Clin Endocrinol Metab. 2007;92(9):3553–9.
Di Dalmazi G, Pagotto U, Pasquali R, Vicennati V. Glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab. 2012;2012:41–9.
Andrews RC, Herlihy O, Livingstone DE, Andrew R, Walker BR. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 2002;87(12):5587–93.
Lucassen EA, Cizza G. The hypothalamic-pituitary-adrenal axis, obesity, and chronic stress exposure: sleep and the Hpa axis in obesity. Curr Obes Rep. 2012;1(4):208–15.
Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865–71.
Ali S, Stone M, Peters J, Davies M, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165–73.
Meurs M, Roest AM, Wolffenbuttel BH, Stolk RP, De Jonge P, Rosmalen JG. Association of depressive and anxiety disorders with diagnosed versus undiagnosed diabetes: an epidemiological study of 90,686 participants. Psychosom Med. 2016;78(2):233–41.
Yu R, Li Y-H, Hong L. Depression in newly diagnosed type 2 diabetes. Int J Diabetes Dev Ctries. 2010;30(2):102.
Shah BM, Gupchup GV, Borrego ME, Raisch DW, Knapp KK. Depressive symptoms in patients with type 2 diabetes mellitus: do stress and coping matter? Stress Health. 2012;28(2):111–22.
Aschbacher K, Kornfeld S, Picard M, Puterman E, Havel PJ, Stanhope K, et al. Chronic stress increases vulnerability to diet-related abdominal fat. Oxidative Stress Metab Risk. 2014;46:14–22.
Bădescu S, Tătaru C, Kobylinska L, Georgescu E, Zahiu D, Zăgrean A, et al. The association between diabetes mellitus and depression. J Med Life. 2016;9(2):120.
Singh M. Mood, food, and obesity. Front Psychol. 2014;5:925.
De Macedo IC, De Freitas JS, Da Silva Torres IL. The influence of palatable diets in reward system activation: a mini review. Adv Pharmacol Sci. 2016;2016:7238679.
Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition. 2007;23(11–12):887–94.
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.
Reynolds RM, Strachan MW, Labad J, Lee AJ, Frier BM, Fowkes FG, et al. Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the edinburgh type 2 diabetes study. Diabetes Care. 2010;33(4):714–20.
Gamede M, Mabuza L, Ngubane P, Khathi A. The effects of plant-derived oleanolic acid on selected parameters of glucose homeostasis in a diet-induced pre-diabetic rat model. Molecules. 2018;23(4):794.
Luvuno M, Khathi A, Mabandla MV. Voluntary ingestion of a high-fat high-carbohydrate diet: a model for prediabetes. Masters of medical science dissertation University of KwaZulu-Natal; 2017.
Mzimela NC, Ngubane PS, Khathi A. The changes in immune cell concentration during the progression of pre-diabetes to type 2 diabetes in a high-fat high-carbohydrate diet-induced pre-diabetic rat model. Autoimmunity. 2019;52:1–10.
Diabetes TOCF. Endocrinology and metabolism. Diabetes trial unit. Homa calculator. http://www.dtu.ox.ac.uk/. Accessed 2016.
Al-Mahmood AK, Ismail AA, Rashid FA, Bebakar WM. Insulin sensitivity and secretory status of a healthy malay population. Malays J Med Sci MJMS. 2006;13(2):37.
Remus JL, Stewart LT, Camp RM, Novak CM, Johnson JD. Interaction of metabolic stress with chronic mild stress in altering brain cytokines and sucrose preference. Behav Neurosci. 2015;129(3):321.
Suvrathan A, Tomar A, Chattarji S. Effects of chronic and acute stress on rat behaviour in the forced-swim test. Stress. 2010;13(6):533–40.
Schmittgen TD, Livak KJ. Analyzing real-time Pcr data by the comparative CT method. Nat Protoc. 2008;3(6):1101.
Lin Y, Sun Z. Current views on Type 2 diabetes. J Endocrinol. 2010;204(1):1–11.
Gamede M, Mabuza L, Ngubane P, Khathi A. Plant-derived oleanolic acid (Oa) ameliorates risk factors of cardiovascular diseases in a diet-induced pre-diabetic rat model: effects on selected cardiovascular risk factors. Molecules. 2019;24(2):340.
Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A. Cardioprotective effects of a ruthenium (Ii) schiff base complex in diet-induced prediabetic rats. Diabetes Metab Syndr Obes Targets Therapy. 2019;12:217.
Tai ES, Goh SY, Lee JJ, Wong M-S, Heng D, Hughes K, et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care. 2004;27(7):1728–34.
Insulin WG, Resistance I. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19.
Reynoso R, Salgado LM, Calderón V. High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Vascular biochemistry. Berlin: Springer; 2003. p. 155–62.
Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010;91(3):502–9.
Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR. The key role of insulin resistance in the cardiometabolic syndrome. Am J Med Sci. 2005;330(6):290–4.
Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007;30(1):83–8.
Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol. 2005;63(6):642–9.
Harrell CS, Burgado J, Kelly SD, Johnson ZP, Neigh GN. High-fructose diet during periadolescent development increases depressive-like behavior and remodels the hypothalamic transcriptome in male rats. Psychoneuroendocrinology. 2015;62:252–64.
Blondeau B, Sahly I, Massouridès E, Singh-Estivalet A, Valtat B, Dorchene D, et al. Novel transgenic mice for inducible gene overexpression in pancreatic cells define glucocorticoid receptor-mediated regulations of beta cells. PLoS ONE. 2012;7(2):e30210.
Lambillotte C, Gilon P, Henquin J-C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Investig. 1997;99(3):414–23.
Adam TC, Hasson RE, Ventura EE, Toledo-Corral C, Le K-A, Mahurkar S, et al. Cortisol is negatively associated with insulin sensitivity in overweight latino youth. J Clin Endocrinol Metab. 2010;95(10):4729–35.
Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91(4):449–58.
Ruzzin J, Wagman A, Jensen J. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia. 2005;48(10):2119–30.
Larsson H, Ahren B. Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity. Diabetologia. 1999;42(8):936–43.
Burén J, Lai Y-C, Lundgren M, Eriksson JW, Jensen J. Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Arch Biochem Biophys. 2008;474(1):91–101.
Ferris HA, Kahn CR. New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it. J Clin Investig. 2012;122(11):3854–7.
Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94–103.
Pandit AU, Bailey SC, Curtis LM, Seligman HK, Davis TC, Parker RM, et al. Disease-Related Distress, Self-Care and Clinical Outcomes among Low-Income Patients with diabetes. J Epidemiol Community Health. 2014;68(6):557–64.
Surwit RS, Schneider MS. Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med. 1993;55(4):380–93.
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Berlin: Springer; 2010.
Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894.
Darwish L, Beroncal E, Sison MV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obesity Targets Therapy. 2018;11:333.
Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017;1391(1):20.
Rutters F, La Fleur S, Lemmens S, Born J, Martens M, Adam T. The hypothalamic-pituitary-adrenal axis, obesity, and chronic stress exposure: foods and Hpa axis. Curr Obes Rep. 2012;1(4):199–207.
Kanter JW, Busch AM, Weeks CE, Landes SJ. The nature of clinical depression: symptoms, syndromes, and behavior analysis. Behav Anal. 2008;31(1):1–21.
Buyukdura JS, Mcclintock SM, Croarkin PE. Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):395–409.
Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015;97:e52587.
Molendijk ML, De Kloet ER. Coping with the forced swim stressor: current state-of-the-art. Behav Brain Res. 2019;364:1–10.
Trunnell ER. Letter to the editor: use of the forced swim test to assess “despair”. Brain stimulation: basic, translational, and clinical research in neuromodulation. 2019.
Molendijk ML, De Kloet ER. Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology. 2015;62:389–91.
Fitzgerald PJ, Yen JY, Watson BO. Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test. PLoS ONE. 2019;14(4):e0215554.
Koek W, Sandoval TL, Daws LC. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57bl/6j mice. Behav Pharmacol. 2018;29(5):453–6.
Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7(6):1009.
Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 2008;33(2):320.
Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology. 2005;177(3):245–55.
Menke A. Is the Hpa axis as target for depression outdated, or is there a new hope? Front Psychiatry. 2019;10:101.
Rogalska J. Mineralocorticoid and glucocorticoid receptors in hippocampus: their impact on neurons survival and behavioral impairment after neonatal brain injury. Vitam Horm. 2010;82:391–419.
Gancheva S, Galunska B, Zhelyazkova-Savova M. Diets rich in saturated fat and fructose induce anxiety and depression-like behaviours in the rat: is there a role for lipid peroxidation? Int J Exp Pathol. 2017;98(5):296–306.
Herman JP, Mcklveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic–pituitary–adrenocortical stress response. Compr Physiol. 2016;6(2):603.
Swierczynska MM, Mateska I, Peitzsch M, Bornstein S, Chavakis T, Eisenhofer G, et al. Changes in morphology and function of adrenal cortex in mice fed a high-fat diet. Int J Obes. 2015;39(2):321.
Mantych GJ, James DE, Devaskar S. Jejunal/kidney glucose transporter isoform (glut-5) is expressed in the human blood-brain barrier. Endocrinology. 1993;132(1):35–40.
Shu H-J, Isenberg K, Cormier R, Benz A, Zorumski C. Expression of fructose sensitive glucose transporter in the brains of fructose-fed rats. Neuroscience. 2006;140(3):889–95.
Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing’s syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol. 2011;4(2):739–69.
Serifoglu I, Oz II, Bilici M. The adrenal gland volume measurements in manifestation of the metabolic status in type-2 diabetes mellitus patients. Int J Endocrinol. 2016;2016:7195849.
Foster MT, Warne JP, Ginsberg AB, Horneman HF, Pecoraro NC, Akana SF, et al. Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint. Endocrinology. 2008;150(5):2325–33.
Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology. 2004;145(8):3754–62.
De Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, et al. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int. 2000;57(4):1329–36.
Gomez-Sanchez EPJS. Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis. Steroids. 2014;91:20–31.
De Kloet ER, Vreugdenhil E, Oitzl MS, Joels MJER. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19(3):269–301.
Zhu L-J, Liu M-Y, Li H, Liu X, Chen C, Han Z, et al. The different roles of glucocorticoids in the hippocampus and hypothalamus in chronic stress-induced Hpa axis hyperactivity. PLoS ONE. 2014;9(5):e97689.
Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2011;301(1):E11–24.
Pariante CM, Lightman SL. The Hpa axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31(9):464–8.
Zhou Q-G, Zhu L-J, Chen C, Wu H-Y, Luo C-X, Chang L, et al. Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci. 2011;31(21):7579–90.